Cleared Traditional

K981929 - BINDAZYME ANTIGLIADIN IGG/IGA COMBI KIT

K981929 is an FDA 510(k) clearance for BINDAZYME ANTIGLIADIN IGG/IGA COMBI KIT, manufactured by The Binding Site, Ltd.. The device is a Class 2 Immunology device with product code MST cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K981929 · The Binding Site, Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1998
Decision
118d
Days
Class 2
Risk

K981929 is an FDA 510(k) clearance for the BINDAZYME ANTIGLIADIN IGG/IGA COMBI KIT. Classified as Antibodies, Gliadin (product code MST), Class II - Special Controls.

Submitted by The Binding Site, Ltd. (Santa Monica, US). The FDA issued a Cleared decision on September 3, 1998 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all The Binding Site, Ltd. devices

FDA 510(k) Submission Details - K981929

510(k) Number K981929 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 1998
Decision Date September 03, 1998
Days to Decision 118 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 105d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MST Device Classification - Class 2, Special Controls

Product Code MST Antibodies, Gliadin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MST Antibodies, Gliadin

All 33
Devices cleared under the same product code (MST) and FDA review panel - the closest regulatory comparables to K981929.
UNICAP GLIADIN IGA ASSAY
K982533 · Pharmacia & Upjohn Co. · Oct 1998
UNICAP GLIADIN IGG ASSAY
K982701 · Pharmacia & Upjohn Co. · Oct 1998
BINDAZYME ANTIGLIADIN IGG
K981644 · The Binding Site, Ltd. · Sep 1998
QUANTA LITE IGA GLIADIN ELISA
K964986 · Inova Diagnostics, Inc. · Jun 1997
IGA ANTI-GLIADIN (IGA-AGA) ANTIBODY TEST KIT
K964341 · Immco Diagnostics, Inc. · May 1997
IGG ANTI-GLIADIN (IGG-AGA) ANTIBODY TEST KIT
K964344 · Immco Diagnostics, Inc. · May 1997